APA (7th ed.) Citation

K, H., K, R., JM, J., H, H., S, M., MJ, B., . . . M, A. (2022). Natural killer cell-mediated ADCC in SARS-CoV-2-infected individuals and vaccine recipients. European journal of immunology, 52(8), 1297. https://doi.org/10.1002/eji.202149470

Chicago Style (17th ed.) Citation

K, Hagemann, et al. "Natural Killer Cell-mediated ADCC in SARS-CoV-2-infected Individuals and Vaccine Recipients." European Journal of Immunology 52, no. 8 (2022): 1297. https://doi.org/10.1002/eji.202149470.

MLA (9th ed.) Citation

K, Hagemann, et al. "Natural Killer Cell-mediated ADCC in SARS-CoV-2-infected Individuals and Vaccine Recipients." European Journal of Immunology, vol. 52, no. 8, 2022, p. 1297, https://doi.org/10.1002/eji.202149470.